No­var­tis backs a $13M round for Anaerophar­ma; Eli Lil­ly in­vest­ing $52M in phar­ma re­search pro­gram with Pur­due

⇨ No­var­tis has joined the syn­di­cate back­ing a $13.1 mil­lion round for Tokyo-based Anaerophar­ma, which is tar­get­ing hy­pox­ic sol­id tu­mors. No­var­tis, Shin­sei Cor­po­rate In­vest­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER